These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 2095036)

  • 1. Orally administered antifungal therapy for experimental keratomycosis.
    O'Day DM
    Trans Am Ophthalmol Soc; 1990; 88():685-725. PubMed ID: 2095036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of therapeutic responses in experimental keratomycosis.
    O'Day DM; Head WS; Robinson RD; Williams TE; Gedde S
    Curr Eye Res; 1992 Jan; 11(1):35-44. PubMed ID: 1313750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.
    Schreiber W; Olbrisch A; Vorwerk CK; König W; Behrens-Baumann W
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2634-43. PubMed ID: 12766067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of efficacy of topical and oral fluconazole treatment in experimental Aspergillus keratitis.
    Avunduk AM; Beuerman RW; Warnel ED; Kaufman HE; Greer D
    Curr Eye Res; 2003 Feb; 26(2):113-7. PubMed ID: 12815530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of corticosteroid on experimentally induced keratomycosis.
    O'Day DM; Ray WA; Head WS; Robinson RD; Williams TE
    Arch Ophthalmol; 1991 Nov; 109(11):1601-4. PubMed ID: 1755744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of extemporaneously prepared miconazole eye drops in Candida albicans-induced keratomycosis.
    Gyanfosu L; Koffuor GA; Kyei S; Ababio-Danso B; Peprah-Donkor K; Nyansah WB; Asare F
    Int Ophthalmol; 2018 Oct; 38(5):2089-2100. PubMed ID: 28900810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model.
    Goldblum D; Frueh BE; Sarra GM; Katsoulis K; Zimmerli S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1359-63. PubMed ID: 15793112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact lens-induced infection--a new model of Candida albicans keratitis.
    O'Day DM; Head WS; Robinson RD; Yang R; Shetlar D; Wang MX
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1607-11. PubMed ID: 10359345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits.
    Hiraoka T; Kaji Y; Wakabayashi T; Nanbu PN; Okamoto F; Oshika T
    Cornea; 2007 Apr; 26(3):336-42. PubMed ID: 17413962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in response in vivo to amphotericin B among Candida albicans strains.
    O'Day DM; Ray WA; Robinson RD; Head WS; Williams TE
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1569-72. PubMed ID: 2016138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical fluconazole for experimental candida keratitis in rabbits.
    Behrens-Baumann W; Klinge B; Rüchel R
    Br J Ophthalmol; 1990 Jan; 74(1):40-2. PubMed ID: 2306443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natamycin treatment of experimental Candida albicans induced keratomycosis in rabbits.
    Saleem M; Rahman A; Afza N
    West Indian Med J; 2007 Dec; 56(6):526-9. PubMed ID: 18646497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new long-acting liposomal topical antifungal formula: human clinical study.
    Abdel-Rhaman MS; Soliman W; Habib F; Fathalla D
    Cornea; 2012 Feb; 31(2):126-9. PubMed ID: 22138587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fungal keratitis at the Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts: retrospective study of 19 cases].
    Rondeau N; Bourcier T; Chaumeil C; Borderie V; Touzeau O; Scat Y; Thomas F; Baudouin C; Nordmann JP; Laroche L
    J Fr Ophtalmol; 2002 Nov; 25(9):890-6. PubMed ID: 12515932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in virulence between two Candida albicans strains in experimental keratitis.
    O'Day DM; Head WS; Csank C; Shetlar DJ; Robinson RD; McCollum GW; Yang R; Zhu TL; Wang MX
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1116-21. PubMed ID: 10752949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
    Habib FS; Fouad EA; Abdel-Rhaman MS; Fathalla D
    Acta Ophthalmol; 2010 Dec; 88(8):901-4. PubMed ID: 19681761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confocal microscopy of Aspergillus fumigatus keratitis.
    Avunduk AM; Beuerman RW; Varnell ED; Kaufman HE
    Br J Ophthalmol; 2003 Apr; 87(4):409-10. PubMed ID: 12642300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Eugenol Successfully Treats Experimental Candida albicans-Induced Keratitis.
    Hassan HA; Geniady MM; Abdelwahab SF; Abd-Elghany MI; Sarhan HA; Abdelghany AA; Kamel MS; Rodriguez AE; Alio JL
    Ophthalmic Res; 2018; 60(2):69-79. PubMed ID: 29969774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular uptake of fluconazole following oral administration.
    O'Day DM; Foulds G; Williams TE; Robinson RD; Allen RH; Head WS
    Arch Ophthalmol; 1990 Jul; 108(7):1006-8. PubMed ID: 2369337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratomycosis caused by Aspergillus viridinutans: an Aspergillus fumigatus-resembling mold presenting distinct clinical and antifungal susceptibility patterns.
    Shigeyasu C; Yamada M; Nakamura N; Mizuno Y; Sato T; Yaguchi T
    Med Mycol; 2012 Jul; 50(5):525-8. PubMed ID: 22329455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.